Rigaku logo

The Science Behind Drug Addiction and Treatment

Apr 11, 2023

We can treat some of areas of addiction through harm reduction, but we will never be able to fully solve it, until we understand the "why" behind it.

In this episode, we speak with Dr. Michael Miller, CEO of the Miller Care Group, about how his clinical approach to addiction differs from others by drilling down into the root causes and treating addiction as the source.

Key topics:

  • The science behind drug addiction
  • How cartels benefit from drug decriminalization
  • The evolution of opioid addiction starting with pain management

 



 

Views expressed in this material are opinions of the host and the guest, and do not necessarily reflect the views of Rigaku Analytical Devices.

Listen and subscribe on your favorite podcast player:

Spotify

Apple Podcasts

To make sure you never miss an episode of The Opioid Matrix, subscribe on Apple Podcasts, Spotify, the website, or your favorite podcast player here: https://plinkhq.com/i/1625927161?to=page  
Michael W. Brown is the global director of counter-narcotics technology at Rigaku Analytical Devices. He has a distinguished career spanning more than 32 years as a Special Agent for the Drug Enforcement Administration (DEA). Most recently he was the DEA Headquarters staff coordinator for the Office of Foreign Operations for the Middle East-Europe-Afghanistan-India. Prior to that he served as the country attaché in India and Myanmar providing foreign advisory support for counter narcotic enforcement. He also spent 10 years in Pakistan as a special advisor to the US Embassy on various law enforcement issues. Michael is a graduate of the United States Ranger Training Battalion and has a master’s degree in Interdisciplinary Technology and Management from the University of Eastern Michigan.

Contact Us

Whether you're interested in getting a quote, want a demo, need technical support, or simply have a question, we're here to help.

Contact Sales
Contact Service
Office Locations